| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate |
1993-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_513480e96105ae9c730ff452c648286a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63f74fcb68852b5bad5d462348350cc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d31ca88079201520937655901a56859b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10f0132d067ef77643746984422a5e9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01d10422731fd1329aaf44e09093667b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c61ac980b48f1d3c68101985a15e42cd |
| publicationDate |
1996-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-94040856-A |
| titleOfInvention |
Vaccine for oral administration |
| abstract |
The invention relates to a vaccine for oral administration containing a complex of antigens and a lipid, the lipid being a glycolipid having a mannose residue and / or a phospholipid being phosphatidylserine. This oral vaccine is able to efficiently produce antibodies to the antigens contained therein after oral administration to living organisms. Therefore, it is now possible to obtain an oral vaccine containing microbial antigens or attenuated microorganisms that could not be absorbed by the oral administration of the vaccine and which could not produce antibodies to antigens in previous practice. |
| priorityDate |
1992-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |